Dataset opportunity
Hannonpharmalink — Regulatory Records Dataset Opportunity
Moderate regulatory records dataset held by Hannonpharmalink, usable for Regulatory RAG and Compliance Copilots.
Score
70
Score (0–100) blends weighted dimensions — dataset rarity, training value, buyer demand, evidence strength and right-to-license. 70+ is deal-ready. See the scored dimensions below for the breakdown.Confidence
56%
Action
Data Sharing Agreement
The recommended deal structure for this dataset: Acquire (full buyout), License (paid usage rights), Data Sharing Agreement (controlled access, no transfer of ownership), Partnership (co-development) or Annotation Program (labeling). Chosen from data ownership, licensing complexity and accessibility.Market
Global pharmaceutical logistics market size was valued at USD 80.56 billion in 2025, projected to exhibit a CAGR of 7.90% (source: Spherical Insights LLP)
Lineage
How this lead was derived
The signal-first chain, end to end: recent external signals → qualified niche → resolved data-holder → site verification → scored opportunity. Every lead is explainable.
Concrete evidence this company actively cares about data — why it's ripe for the deal room.
- 📣Press / announcement
Investment in specialized refrigerated fleet with integrated tracking
source ↗
Profile
Dataset profile
Type
Regulatory Records Dataset
Modality
Text
Sector
mobility
Volume
Moderate
Freshness
Real-time
Rarity
High (proprietary)
Accessibility
Restricted
Legal
Owned by the company — GDPR-sensitive (PII review)
Buyer persona
RegTech & compliance-AI vendors
Hannonpharmalink provides a Regulatory Records Dataset in Text modality, compiled from a rich mix of APIs, event streams, IoT data, and formal regulatory filings. This data offers a granular, evidence-based view of pharmaceutical logistics operations, making it exceptionally suited for a Regulatory RAG use case by enabling an AI to retrieve and synthesize precise compliance and operational answers from complex, multi-format source material.
The global pharmaceutical logistics market was valued at USD 80.56 billion in 2025 and is projected to grow at a CAGR of 7.90%. [2] This dataset's value is amplified by its rare combination of sensitive pharmaceutical supply chain information and temperature-controlled logistics logs, which are subject to strict GDP compliance. While access requires group-level approval from Hannon Group, the data's depth and direct applicability to high-value AI compliance automation make it a compelling asset for sophisticated buyers. ⚠ Diligence (valuable data, access to negotiate): Data includes sensitive pharmaceutical supply chain information.; Temperature-controlled logistics logs are subject to strict regulatory compliance (GDP).; Part of the larger Hannon Group, requiring group-level data sharing approval. · corporate: subsidiary of Hannon Group.
Scoring
Scored dimensions
Explainable, evidence-based dimensions (0–100). The radar shows the investment axes.
This evidence collectively proves Hannonpharmalink holds a proprietary dataset detailing the complete lifecycle of pharmaceutical shipments, including regulatory compliance records, real-time IoT sensor data, and end-to-end event streams. For RegTech and compliance-AI vendors, this is a rare source of ground-truth data essential for training Regulatory RAG models that can automate audits and ensure GDP compliance. In a pharmaceutical logistics market projected to grow at nearly 8% annually, this dataset offers a significant competitive edge by enabling next-generation compliance solutions.
See dimension details ↓- ICP Audit100
✓ good target — This is a perfect target: a specialized logistics SME with a real operational business and its own fleet, generating proprietary, dormant data as a by-product of its core transport services.
- Deep Qualification90
⚠ needs review — Hannonpharmalink is a logistics service provider, not a data seller; the data, likely owned by its clients, is a plausible but highly restricted byproduct of its regulated transport operations. [data is owned by the company's customers; licensing restricted]
- Dataset Specificity90
dominant 'regulatory', sector mobility, 3 specific types
How sharply the data targets a specific, hard-to-substitute domain or task. Niche, well-defined data scores higher than generic. - Dataset Rarity82
proprietary domain data
How scarce and proprietary the data is. Unique domain data scores high; openly available data lowers it. - Dataset Volume58
4 evidence hits
Apparent scale of the data, inferred from the number of evidence hits and any explicit volume mentions. - Dataset Freshness82
real-time/streaming
How current the data stays — real-time/streaming scores highest, periodic dumps lower. - Training Value84
fit for Regulatory RAG
How useful the data is for the target AI use-case — its fit for model training or fine-tuning. - Buyer Demand80
AI buyer demand is strong, driven by the need to automate compliance and enhance efficiency in the rapidly growing pharmaceutical logistics market (CAGR of 7.90%). [2]
How strongly AI builders and companies are likely to want this data, based on market signals. - Legal Accessibility32
open/API access
How legally easy the data is to obtain and use — open/API access scores high; PII or regulated data scores low. - Acquisition Feasibility0
medium difficulty, subsidiary of Hannon Group
How realistic it is to actually obtain the data, given access difficulty and the holder's corporate structure. - Evidence Strength74
4 evidence types, 4 hits
How solid the proof is that the company holds this data — diversity of evidence types and number of hits. - Right to License62
ownership=owned, licensing=gdpr_sensitive
Whether the company can legally license the data out — based on ownership and licensing complexity. - Corporate Independence50
subsidiary of Hannon Group
Whether the holder can decide alone — an independent company scores higher than a subsidiary of a large group. - Data Orientation39
1 data-appetite signals (1 types)
How actively the company invests in data, measured by its data-appetite signals (hires, products, APIs…). - Dormant Data Surplus92
surplus=high — proprietary data beyond what's already monetised
Volume and value of proprietary data this company holds BEYOND what it already monetises — the dormant surplus we can unlock. A company can sell some insights AND still sit on a far larger dormant asset.
Evidence
Dataset evidence & lineage
What the typed evidence proves the company holds — reframed for clarity and set against the market.
API access
This evidence points to documentation for a quality management system for handling Active Pharmaceutical Ingredients, a critical component for any vendor serving the regulated pharmaceutical supply chain.
IoT / sensor data
The company generates valuable time-series data from its real-time temperature monitoring and GPS tracking systems, which is essential for cold chain validation and risk management applications.
Regulatory records
This text-based dataset contains the traceability records and audit trails necessary to prove compliance with Good Distribution Practice (GDP), directly feeding regulatory reporting and AI-powered compliance models.
Event streams
The holder captures detailed event streams that provide end-to-end visibility of shipment movements, offering granular data on transit times and logistics handoffs for supply chain optimization models.
Marketplace
Dataset details
Detailed schema & sample available on access request.
Coverage
Scanned sources
Deliverable
Premium dataset report
Hannonpharmalink Regulatory Records — a Moderate regulatory records dataset (Text modality) in the mobility domain. Primary AI use-case: Regulatory RAG. Market signal: Global pharmaceutical logistics market size was valued at USD 80.56 billion in 2025, projected to exhibit a CAGR of 7.90% (source: Spherical Insights LLP). Investment score 70.0/100 (confidence 0.56). Recommended action: Data Sharing Agreement.
From the marketplace
Explore live data opportunities
Paua — Mobility Telemetry Dataset Opportunity
View opportunity →industrialValaratomics — Regulatory Records Dataset Opportunity
View opportunity →mobilityTrucksters — Mobility Telemetry Dataset Opportunity
View opportunity →Data Academy
Learn before you deal
- What you are entitled to sell3 min read
- 5 Mistakes That Drive Buyers Away3 min read
- Why Buy External Data?3 min read